Mast cells are critical effector cells in
Itk is activated in mast cells upon FcεRI-mediated signaling and Itk -/-mice have been reported to display decreased mast cell degranulation and histamine release in vivo (2, 4) . However, our analysis of Itk null mast cells revealed that the absence of Itk does not intrinsically affect mast cell degranulation either in vitro or in vivo (5) . Although Itk is critical for TCRmediated induction of intracellular Ca 2+ mobilization and Erk activation, Itk is not required for intracellular calcium signaling in response to FcεRI-mediated signaling in mast cells, and Itk-deficient mast cells secrete elevated cytokines upon activation (5) . Collectively, these data strongly suggests that Itk has cell typespecific functions.
In mast cells, Btk is activated by the FcεRI, c-Kit and IL-3 receptors (6-8). It's function has been well studied in B cells where it is activated downstream of the BCR (9, 10) . Loss of Btk function in humans causes X-linked agammaglobulinemia (XLA), a condition where patients do not have sufficient immunoglobulins, with a milder phenotype observed in Btk-deficient mice (11, 12) .
In mast cells, Btk is activated by the FcεRI, c-Kit and IL-3 receptors (6) (7) (8) . Mast cell development appears normal in the absence of Btk, both in vivo and in vitro. However, more bone marrow-derived mast cells (BMMCs) cells are produced from Btk-deficient mice in response to IL-3 (7). Btk -/-BMMCs also exhibit mild to moderate impairment of early and late FcεRI-mediated responses such as degranulation, histamine release, and cytokine production, including TNF-α, IL-2, IL-6, IL-13, and GM-CSF (8, 13 (9) ) all on a C57Bl/6 background were kept in microisolater cages in the animal facilities at The Pennsylvania State University. Itk/Btk double knockout mice (DKO) were generated by crossing Itk and Btk null mice. Mice were provided with food and water ad libitum. Passive systemic anaphylaxis responses were performed as previously described (5) . All experiments were approved by the Office of Research Protection's IACUC at The Pennsylvania State University.
Armenian hamster anti-mouse FcεRI alpha were purchased from eBioscience (San Diego, CA). B cells were analyzed in the spleen as previously described (5) . Similarly, analysis of NFAT nuclear localization was as previously described (5) . or Itk/Btk DKO mice as previously described, except that medium was added every 48 hrs and cell numbers re-adjusted to 0.5 x 10 6 /ml and transferred to new flasks every 4 days. Contaminating adherent cells were removed every 4 days by transferring cells in suspension to new flasks until no more adherent cells could be detected in cultures (5) . Mast cell culture purity was assessed by double staining with FITClabeled anti-c-kit and PE-labeled anti-FcεRI-α and were at least ≥ 95% double positive for c-Kit and FcεRI-α.
Generation of bone marrow-derived mast cells (BMMCs)-
Multiplexed Cytokine Assay-Cytokine secretion in BMMCs was determined as previously described (5) . Briefly BMMCs were starved of IL-3in complete media overnight, along with sensitization with anti-DNP-IgE. Cells were then stimulated with 30 µg/ml rat anti-mouse IgE or 50 ng/ml PMA and 500 nM ionomycin in culture medium in a final volume of 100 µl. After 24 h of stimulation, plates were centrifuged and supernatants collected for cytokine analysis. Total levels of secreted TNFα, IL-2, IL-3, IL-4, and GM-CSF were measured by the Milliplex multiplex system (Millipore) following manufacturer's instructions.
Protein analysis-Mast cells were sensitized with anti-DNP-IgE overnight in the absence of IL-3, but in the presence of complete media, and then stimulated with 100 ng/ml DNP-HSA, or 30 µg/ml rat anti-mouse IgE, for the indicated time in the figures. Cells were lysed in ice cold lysis buffer, (50 mM Tris pH 7.6, 150 mM NaCl, 1 mM EDTA, 10% glycerol, 1% NP-40, 0.1% SDS, 1% Na deoxycholate, 1 mM NaF, 10 mM Na orthovanadate, 1 mM PMSF, 1 µg/ml pepstatin and Roche's complete Protease inhibitor cocktail (Roche, Indianapolis, IN)) and snap frozen in liquid nitrogen. Samples were thawed and SDS-PAGE and western blotting carried out as described (3, 5) . , and Itk/Btk DKO bone marrow cells were washed twice in PBS and seeded in equal numbers into culture flasks. The gross cell numbers were monitored over a period of 3 weeks and the average cell number plotted +/-SEM.
Analysis of skin mast cells-
Boolean Network analysis-Network analysis was performed using Booleannet1.2 (14) as detailed in the supplemental material.
Rules were generated that followed the experimental observations and used to model potential pathways leading to the production of cytokines in BMMCs, and the potential role of Itk, Btk or both in these pathways. Plots of those networks were generated using Cytoscape (15) . Fig. 1A) .
Statistics-
Examination of mast cell numbers and distribution in the skin of respective mice revealed no statistically significant differences in their numbers and distribution (WT = 41 cells/mm , and Itk/Btk DKO = 51 cells/mm 2 ,p=0.230). However, the structure of the Itk/Btk DKO mast cells was significantly altered, as depicted by a reduction in their granular density when compared to WT, Itk -/-and Btk -/-mast cells (Fig. 1A) .
This was confirmed by transmission electron microscopic analysis (Fig. 1B) . Here, the membrane-bounded granules appeared to have lower electrondensity and some were half-empty, suggesting possible occurrence of degranulation (16 , and Itk/Btk DKO mice. Mice were injected with anti-DNP IgE, and 24 hours later, DNP-HSA was administered intravenously followed by measurement of histamine release in the serum. As shown in figure 2, WT mice responded to antigen challenge with increased histamine levels in sera, while Btk -/-, and as previously reported Itk -/-mice had significantly lower levels of serum histamine following antigen challenge (4, 5) , and this response was significantly more pronounced in the Itk/Btk DKO mice ( Fig.  2A) .
Increased occupancy of FcεRI by IgE on Btk -/-and Itk/Btk DKO peritoneal mast cells
We have previously reported that Itk -/-mice exhibit decreased histamine release in vivo, while BMMCs from these mice could degranulate efficiently in vitro, as well as in vivo when transferred to mast cell deficient mice. This lower histamine response observed in Itk -/-mice was due to elevated levels of serum IgE, causing higher occupancy of the FcεRI by endogenous IgE and consequently lower binding of the experimental antigen-specific IgE used for passive sensitization in vivo (5) . We considered this as a possible explanation for the lower histamine release after challenge in Itk/Btk DKO mice, and therefore determined the levels of IgE in their serum. We found that both Itk -/-and surprisingly, Btk -/-mice have higher levels of serum IgE when compared to WT mice (Fig. 2B) . More strikingly, the Itk/Btk DKO mice had even higher levels of serum IgE when compared to either the Itk -/-or Btk -/-mice (Fig. 2B) .
These results were also consistent with an increased percentage of class switched B cells observed in the spleen in the absence of Itk, Btk or both kinases (Fig. 2E) . The absence of Itk had a more pronounced effect on the number IgE class switched B cells. These data collectively suggested a strong negative correlation between total serum IgE and the in vivo response observed after passive sensitization with experimental IgE and subsequent DNP-HSA stimulation (Fig. 2C) .
Analysis of peritoneal mast cells by flow cytometry revealed that the elevated serum IgE observed in Btk -/-and Itk/Btk DKO mice concurrently leads to higher levels of FcεRI occupancy by IgE on the surface of these mast cells (Fig. 2D) (Fig. 3A) . Similarly, TEM analysis of BMMCs revealed little difference in overall ultrastructure, unlike what was observed in vivo (cf. Fig. 3B and Fig. 1B) . However, analysis of the overall growth of bone marrow cells over a 3-week period suggested increased growth of Btk deficient bone marrow cells as previously published (17) , as well as Itk/Btk DKO cells. No significant differences in growth were observed between WT and Itk -/-cells (Fig.  3C) . By contrast, once cells have matured to BMMCs, there is no apparent difference in growth in response to IL-3 (Fig. 3C) . In addition, there was no change in the expression of Itk in Btk null BMMCs, nor in Btk expression in Itk null BMMCs (data not shown).
Compromised degranulation in Itk/Btk DKO BMMCs in vitro in response to antigen-mediated FcεRI stimulation
We further analyzed BMMCs for their ability to degranulate in vitro as measured by total β-hexosaminidase activity released after antigen-mediated FcεRI stimulation. Itk -/-BMMCs responded with higher levels of degranulation, when compared to WT BMMCs (Fig. 4A) . By contrast, the response of Itk/Btk DKO BMMCs was severely impaired (Fig. 4A) , while Btk -/-BMMCs responded slightly lower than WT at some concentrations of antigen, although this was not significantly different from WT BMMCs.
However, when PMA/Ionomycin was used to bypass Itk or Btk in the early FcεRI signaling pathway, the degranulation responses were similar in all four strains (Fig. 4A) . These data indicate that both Itk and Btk participate in FcεRI mediated degranulation.
Differential role of Itk and Btk in FcεRI-mediated intracellular calcium release in BMMCs
The level of degranulation in mast cells is known to be dependent on intracellular calcium release following FcεRI stimulation (18) . Although previous reports suggest that the absence of Itk either has no effect or in some cases results in slight increases in intracellular calcium in mast cells, Btk appears to have a more important role in this process (6 (Fig. 4C) . In Itk/Btk DKO BMMCs, PLCγ2 tyrosine phosphorylation was similar to that observed in Btk -/-BMMCs (Fig. 4C) .
Differential regulation of MAP kinases p38 and ERK by Itk and Btk in mast cells
Analysis of FcεRI induced activation of the MAPK p38 revealed that the absence of either Itk or Btk led to enhanced activation of this kinase. However, similar to that observed for PLCγ2, the absence of both Itk and Btk led to significant reductions in the activation of p38 (Fig. 5A) . In contrast, FcεRI mediated activation of ERK behaved differently, where the absence of Itk or Btk resulted in reduced activation of this pathway, while the absence of both kinase paradoxically led to enhanced activation of this pathway (Fig.  5B) . Stimulation with anti-DNP IgE and DNP-HSA led to similar conclusions, although overall activation of the ERK pathway was lower, and the differences seen in the absence of Itk or Btk were less apparent, however the absence of both kinases resulted in increased ERK activation (Fig. 5C) . It is possible that the extensive crosslinking that occurs with anti-IgE compared to DNP-HSA results in enhanced signaling, which reveals the differences in BMMCs lacking Itk or Btk.
Differential regulation of NFAT and cytokine secretion by Itk and Btk in BMMCs
We have previously shown that the absence of Itk leads to enhanced secretion of several cytokines in BMMCs (5). We therefore examined whether the absence of both Itk and Btk would affect the secretion of specific cytokines following FcεRI stimulation. As previously reported, the absence of Itk led to enhanced secretion of IL-2, IL-3, IL-4 and GM-CSF 24 hours following FcεRI stimulation (Fig. 6A-E)(5) . In contrast, TNF-α secretion was not affected by the absence of Itk in these experiments. While the absence of Btk resulted in the decreased secretion of IL-2 and IL-4, the absence of both Itk and Btk led to a further reduction in IL-2 secretion. Analysis of Itk/Btk DKO BMMCs revealed that secretion of GM-CSF was lower in the absence of both Itk and Btk, although it was not affected by the absence of Btk alone. Meanwhile, the secretion of IL-4 and TNF-α in Itk/Btk DKO BMMCs was not affected beyond that seen in the absence of Btk alone. On the other hand, while secretion of IL-3 was enhanced in the absence of either Itk or Btk, it was significantly lower in the absence of both kinases.
As most of these cytokines are regulated by the transcription factor NFAT, we examined activation of NFAT1/NFATc2 following FcεR triggering in the BMMCs. We found that, as previously reported, Itk null BMMCs have elevated NFAT in the nucleus prior to stimulation, which increased upon stimulation (Fig. 7A) . WT and Btk null BMMCs have similar levels of nuclear NFAT prior to stimulation, and both responded with increased nuclear NFAT. However, while a higher percentage of Itk/Btk DKOs had increased nuclear NFAT1/c2, similar to Itk null BMMCs, these cells responded much less upon stimulation (Fig. 7A) . Examination of the fold increase in NFAT1 intensity in the nucleus revealed that WT mice responded best, followed by Itk null BMMCs (Fig.  7B) . By contrast, Btk null and Itk/Btk DKO BMMCs responded poorly. These data suggest that Btk and Itk differentially regulate basal and stimulated NFAT nuclear localization, which may contribute in part to the differential regulation of cytokine secretion observed.
Boolean network analysis of cytokine secretion
Boolean network analysis can facilitate the understanding of combinatorial interactions (14, 19, 20) . We developed a Boolean network model of these interactions in an effort to simplify interpretation of these data. We searched for Boolean rules (AND, OR, or NOT) that would describe the interaction between Itk and Btk, which would result in the observed pattern of cytokine secretion (see materials and methods). This network analysis revealed specific Boolean conditions that satisfy the observed data using a hybrid Boolean network ((14), Fig. 8 ). Using this hybrid Boolean network, we simulated the rules suggested by the data in figure 6A -E for the indicated cytokines.
We searched for Boolean rules that would qualitatively predict the observed cytokine secretion pattern in the presence of either kinases (WT condition), the absence of either Itk or Btk, or both (all pathways are assumed to be indirect or involve multiple intermediates). The relative importance of the pathway is indicated by the thickness of the lines in the arrows. In the case of IL-2, we found that a Btk regulated pathway (referred to as Pathway Btk or Pa B) downstream of the FcεRI positively regulated IL-2 production and in the absence of Btk little IL-2 is produced, satisfying the conditions in our simulations.
By contrast, a pathway (referred to as Pathway Itk or Pa I) negatively regulated IL-2 secretion such that in its absence, more IL-2 is produced. However, the absence of both Itk and Btk (and thus both Pa B and Pa I) leads to little IL-2 production. Also depicted in the network is an obligate non-Itk, non-Btk pathway from the FcεRI (Pathway FcεRI or Pa F) which by itself is not sufficient for IL-2 secretion (Fig. 8A) . Note that Pa B, Pa I and Pa F could be single or multicomponent pathways, signaling molecules, second messengers or transcription factors. Similar treatment and simulations for IL-3 led to the simple pathway shown, which suggests that either Itk or Btk could satisfy the requirement for the secretion of IL-3, but that in the absence of both, little IL-3 is secreted (Fig. 8B) . Analysis of rules for the secretion of IL-4 and TNF-α revealed that these two cytokines have similar requirements for Btk, lack of requirement for Itk, and a Btk/Itk independent component emanating from the FcεRI (Fig.  8C, D) . In the case of these two cytokines, the rules that satisfied the observed pattern of secretion included a rule for approximately 50% of cytokines produced as a result of this Btk/Itk independent component, while Btk regulated signals controlled the remaining production. Finally, analysis of rules for the secretion of GM-CSF led to the more complicated network depicted (Fig. 8E) . These rules suggest that Btk regulated Pa B provided positive signals for the production of this cytokine, while Itk provided both a positive signal (referred to as Pathway Itk2 or Pa I2) as well as the negative Pa I pathways discussed in reference to IL-2. In addition, there is an Itk/Btk independent FcεRI regulated pathway that is insufficient on its own to induce GM-CSF secretion in the absence of Itk and Btk. Simulations using the rules depicted in figure 8 led to the predicted cytokine secretion patterns, which is very similar to the observed pattern of cytokine secretion (Figs. 6, 8) . Altogether, these simulations suggest that IL-2 and GM-CSF, and IL-4 and TNF-α are related in their pattern of regulation by Itk and Btk, while IL-3 is regulated differently by these two patterns (Fig. 8F) .
DISCUSSION
Protein kinases play important roles in regulating cell function. As such these enzymes have been attractive drug targets to treat numerous health conditions, such as mast cell driven anaphylactic responses. Unfortunately, most therapeutic efforts are often hindered by unwanted side effects or toxicity of these drugs, frequently the result of poor drug specificity and/or full understanding about the biochemical pathways regulated by these proteins. Several studies have addressed the idea of targeting intracellular protein tyrosine kinases to block mast cells responses to allergens (21) (22) (23) (24) (25) Similar analysis of cytokine secretion revealed that Btk contributes positively to the secretion of IL-2, IL-3, IL-4, TNF-α and GM-CSF. By contrast, Itk contributes both positively (to secretion of IL-3 and GM-CSF), and negatively (to IL-2 and GM-CSF) but does not make significant contributions to the secretion of IL-4 and TNF-α in this analysis. Altogether, our data suggests that both Btk and Itk contribute the mast cell function in response to IgE/antigen stimulus in a complex fashion.
In the course of our studies, we observed that as previously reported, Itk -/-mice have high levels of serum IgE (5). We and others have recently reported that this is due to altered development of a unique γδ T cell population carrying the Vγ1/Vδ6.2/3 receptor, which secretes significant levels of IL-4 and can induce class switch in B cells (26, 27) . Indeed, significantly more B cells have undergone class switch to IgE in mice lacking Itk than WT mice (5). However, we also find that mice lacking Btk have elevated levels of serum IgE, although this is not accompanied by a similar increase in the percentage of IgE class switched B cells. Kawakami and colleagues have suggested that Btk null dendritic cells are predisposed to generating Th2 responses due to lower production of IL-10, and it is possible that this leads to enhanced IgE secretion by class switched B cells and elevated serum IgE (28) . Even more striking was the extreme elevation of serum IgE in the Itk/Btk DKO mice, which may be a combination of the unique γδ T cell population and altered dendritic cell function. Experiments are underway to test these possibilities.
We have previously demonstrated that the elevated serum IgE in Itk null mice explains the discrepancy between the observed defect in mast cell degranulation in vivo, and in in vitro derived BMMCs (4, 5) . Btk null mice have previously been reported to have decreased mast cell degranulation in vivo, although the severity of this decrease differs dependent on the antigen concentration being used (13) . In our experiments, while we found that Btk -/-BMMCs responded slightly below the WT response in the degranulation response to IgE triggering, this was not a significant difference. It is possible that our WT responses were not optimal although this behavior was observed in 2-3 independent bone marrow cultures. In their analysis of Btk -/-BMMCs, Kawakami and colleagues reported differences in degranulation between WT and Btk -/-BMMCs, which was mostly apparent at lower doses of antigen (13), while Takatsu and colleagues reported larger differences (6) . It is possible that the maturation status of our BMMC cultures may be subtly different from those used in our reports. However, the observed reduced degranulation in the Btk -/-and Itk/Btk DKO mice in vivo could be due to the constitutive occupancy of the FcεRs on their mast cells, thus precluding binding of the exogenously delivered anti-DNP-IgE, leading to the observed lower levels of histamine. These in vivo assays may therefore be less informative with regards to antigen specific FcεR function on their mast cells. However, in the case of the Itk/Btk DKO mice, in vitro derived BMMCs also exhibit defects in degranulation, suggesting that in this case, there is a defect that is intrinsic to the mast cell. It should be noted however, that with the extremely elevated serum IgE observed in the Itk/Btk DKO mice, the occupancy of FcεRI by these IgE molecules could potentially led to aggregation of the FcεRI receptor and cause spontaneous degranulation in peritoneal mast cells and presumably in tissue mast cells including skin mast cells. Detailed analysis of the mast cell ultra structure by electron microscopy reveals that the membranes covering the granules may be fusing with the plasma membrane.
However, mast cell development is not affected in any of the knockouts, with no differences in total mast cells numbers. Btk is known to play a role in regulating apoptosis mediated by growth factor deprivation, and has been implicated in control of the cell cycle in mast cells (7, 17) . Indeed, we observed that Itk/Btk DKO BMMCs can be generated in vitro with normal morphology, granule shape and size, although bone marrow-derived cells from both Btk -/-(as previously reported (17)), as well as Itk/Btk DKO have increased growth compared to WT cells in response to IL-3.
However, once differentiated, the BMMCs exhibit no differences in growth to IL-3 in vitro.
Analysis of FcεRI signaling reveals that Itk/Btk DKO BMMCs have decreased Ca 2+ mobilization and PLCγ2 phosphorylation, similar to the Btk -/-BMMCs (13). Since degranulation is dependent on calcium, it is clear that both of these processes require the presence of Btk in mast cells. Although Itk is involved in mediating Ca 2+ mobilization in T cells, it either plays a negative role or does not affect this process in mast cells. Interestingly neither kinase is required for ERK activation in mast cells and may even negatively regulate the activation of this pathway. However, the absence of either Itk or Btk does have a small effect on the activation of this pathway. By contrast, the p38 pathway seems to be negatively regulated by both Itk and Btk, but in the absence of both kinases, it is decreased. This implies that both Itk and Btk may regulate select pathways in mast cells.
Our analysis of cytokine secretion by BMMCs lacking Itk, Btk or both was also revealing. We determined that as previously reported, Btk positively regulates IL-2 and TNF-α, while Itk negatively regulates IL-2 and GM-CSF (5, 29) . However, using Boolean network analysis and simulations, we were able to find conditions that would logically satisfy the complex role these two kinases play in regulation of the cytokines examined.
While these conditions do not provide exact pathway members, they provide us with information about the nature of the similarities between their requirements. We believe that such analysis has promise in being able to qualitatively analyze and distill complex observations or pathways to a more simplified form. This analysis allowed us to determine that IL-2 and GM-CSF behave similarly in their regulation by Itk and Btk, while IL-4 and TNF-α had similar requirements. It is possible that in depth analysis of the pathways leading to these cytokines may reveal biochemical similarities in their regulation.
Our analysis of NFAT1/c2 nuclear localization revealed that the absence of Itk leads to elevated nuclear localization of NFAT, in the presence or absence of Btk, suggesting that this pathway may be independent of any Btk influence. However, enhanced basal nuclear localization of NFAT1/c2 did not result in enhanced cytokine secretion as the Itk/Btk DKO BMMCs had lower levels of cytokine secretion upon stimulation. By contrast, the fold increase in NFAT1/c2 nuclear localization correlated better with cytokine secretion, suggesting that cytokine secretion may follow Weber's law, in that the relative fold increase in nuclear NFAT1/c2 compared to the background may be a more critical determinant of subsequent cytokine response than the absolute amount of nuclear NFAT1/c2 (30) . While this has been observed for several signaling pathways, this idea remains to be more rigorously tested in this setting in future experiments.
It is possible that other Tec kinases, such as Tec, may be able to play some redundant role in these processes (3). Indeed, BMMCs lacking Tec also have enhanced growth in vitro in response to IL-3. In addition, Btk/Tec DKO BMMCs have decreased PLCγ1 tyrosine phosphorylation and calcium responses, but the absence of Tec does not affect activation of ERK or p38 MAPKs. Tec null BMMCs do show lower secretion of TNF-α and GM-CSF, and more dramatically IL-4, and the absence of Btk and Tec led to significant defects in secretion of TNF-α, GM-CSF and IL-4. However, these analyses of cytokine secretion were preformed in the presence of IL-3, which prevents us from directly comparing our findings with the findings of Ellmeier and colleagues (3) . Further analysis of mice lacking other multiple combinations of Tec kinases promises to reveal more about the function of these kinases in mast cells.
Tec kinase inhibitors have not been used to treat allergic disorders to date, although there is considerable interest in the use of this approach. In mast cell function, Btk seems to be more important due to its role in regulating FcεRI mediated Ca 2+ mobilization and degranulation. However, our work suggests that Itk also plays a more complicated role, both positive and negative, in this process. Our work also suggests that inhibiting both Itk and Btk may be more beneficial in reducing mast cell responses, while targeting Itk alone may not have the desired effect of inhibiting mast cell degranulation, or affecting specific cytokine secretion. 
